Patents by Inventor Michelle Elizabeth Hung

Michelle Elizabeth Hung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12005081
    Abstract: Provided herein are acute myeloid leukemia antigen targets for chimeric receptors and methods of using same.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: June 11, 2024
    Assignee: Senti Biosciences, Inc.
    Inventors: Brian Scott Garrison, Jennifer Chien, Kathryn Armstrong Loving, Russell Morrison Gordley, Michelle Elizabeth Hung
  • Publication number: 20240182910
    Abstract: Provided herein are synthetic inducible transcription factors that can be activated by a cognate ligand (e.g., caffeine, a cannabinoid, nicotine, rapamycin, or mifepristone) and isolated cells expressing the inducible transcription factors. Also provided are methods of modulating transcription of a gene of interest using an inducible transcription factor.
    Type: Application
    Filed: October 18, 2023
    Publication date: June 6, 2024
    Inventors: Michelle Elizabeth Hung, Russell Morrison Gordley
  • Publication number: 20240150433
    Abstract: Provided herein are mutants of estrogen receptor alpha ligand binding domain (ER-LBD), and chimeric proteins including such mutant ER-LBD. Also provided are methods of modulating transcription and modulating localization of such chimeric proteins.
    Type: Application
    Filed: October 5, 2023
    Publication date: May 9, 2024
    Inventors: Michelle Elizabeth Hung, Rebecca Tayler Cottman, Russell Morrison Gordley, Gary Lee, Timothy Kuan-Ta Lu, Srinivasaraghavan Kannan, Chandra Shekhar Verma
  • Publication number: 20240141364
    Abstract: Provided herein are chimeric polypeptides for drug-regulated transcriptional repression. Also provided are methods of inhibiting repression of a gene of interest.
    Type: Application
    Filed: October 6, 2023
    Publication date: May 2, 2024
    Inventors: Michelle Elizabeth Hung, Rebecca Tayler Cottman, Russell Morrison Gordley
  • Publication number: 20240131159
    Abstract: Provided herein are mutants of estrogen receptor alpha ligand binding domain (ER-LBD), and chimeric proteins including such mutant ER-LBD. Also provided are methods of modulating transcription and modulating localization of such chimeric proteins.
    Type: Application
    Filed: October 4, 2023
    Publication date: April 25, 2024
    Inventors: Michelle Elizabeth Hung, Rebecca Tayler Cottman, Russell Morrison Gordley, Gary Lee, Timothy Kuan-Ta Lu, Srinivasaraghavan Kannan, Chandra Shekhar Verma
  • Publication number: 20240091358
    Abstract: Described herein are chimeric proteins including membrane-cleavable chimeric proteins and degron-fusion chimeric proteins. Also described herein are nucleic acids, pharmaceutical compositions, methods, and methods of treatment directed to the same.
    Type: Application
    Filed: July 13, 2023
    Publication date: March 21, 2024
    Inventors: Michelle Elizabeth HUNG, Russell Morrison GORDLEY
  • Publication number: 20240082303
    Abstract: Described herein are chimeric proteins, specifically membrane-cleavable chimeric systems. Also described herein are nucleic acids, cells, and methods directed to the same.
    Type: Application
    Filed: May 4, 2023
    Publication date: March 14, 2024
    Inventors: Michelle Elizabeth HUNG, Russell Morrison GORDLEY, Gary LEE
  • Publication number: 20230405144
    Abstract: Provided herein are compositions and methods for inducing cell death in a regulated manner, for example in a safety switch system. Inducible cell death can be triggered by ligand binding to a one or more ligand binding domains. Cell death can include induction of apoptosis.
    Type: Application
    Filed: May 18, 2023
    Publication date: December 21, 2023
    Inventors: Rocky CHEUNG, Russell Morrison GORDLEY, Timothy Kuan-Ta LU, Michelle Elizabeth HUNG, Rebecca Tayler COTTMAN
  • Publication number: 20230372486
    Abstract: Provided herein are EMCN-specific antigen-binding domains, and chimeric proteins including the EMCN-specific antigen-binding. Also provided herein are cells, nucleic acids, vectors, compositions, and methods directed to proteins including the EMCN-specific antigen-binding domains.
    Type: Application
    Filed: April 14, 2023
    Publication date: November 23, 2023
    Inventors: Brian Scott GARRISON, Michelle Elizabeth HUNG, Nicholas FRANKEL
  • Publication number: 20230011052
    Abstract: Provided herein are compositions and methods for regulating expression of effector molecules using regulatable transcription factors and/or activation inducible promoters.
    Type: Application
    Filed: June 10, 2022
    Publication date: January 12, 2023
    Inventors: Marcela Guzman Ayala, Russell Morrison Gordley, Michelle Elizabeth Hung, Gary Lee, Jack Tzu-Chiao Lin, Timothy Kuan-Ta Lu, Assen Boyanov Roguev
  • Publication number: 20220396609
    Abstract: Provided herein are generalized extracellular molecule sensors (GEMSs) and polynucleotides encoding the GEMSs. Also provided herein are methods of making and using the GEMSs, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 15, 2022
    Inventors: Russell Morrison Gordley, Daniel Frimannsson, Michelle Elizabeth Hung
  • Publication number: 20210299177
    Abstract: Provided herein are acute myeloid leukemia antigen targets for chimeric receptors and methods of using same.
    Type: Application
    Filed: June 3, 2021
    Publication date: September 30, 2021
    Inventors: Brian Scott Garrison, Jennifer Chien, Kathryn Armstrong Loving, Russell Morrison Gordley, Michelle Elizabeth Hung